Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case-control study of leukemia and diagnostic radiation exposure.
Yuasa H, Hamajima N, Ueda R, Ohno R, Asou N, Utsunomiya A, Ogura M, Takigawa N, Ueda T, Hiraoka A, Matsuda S, Kuraishi Y, Nishikawa K, Uike N, Takeshita A, Takemoto Y, Shimazaki C, Sakamaki H, Ino T, Matsushima T, Kuriyama K, Hirai H, Naoe T, Tsubaki K, Takahashi I, et al. Yuasa H, et al. Among authors: ueda t, ueda r. Int J Hematol. 1997 Apr;65(3):251-61. doi: 10.1016/s0925-5710(96)00556-7. Int J Hematol. 1997. PMID: 9114596
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.
Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R. Naoe T, et al. Among authors: ueda r. Clin Cancer Res. 2000 Oct;6(10):4091-5. Clin Cancer Res. 2000. PMID: 11051261
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.
Kagami Y, Itoh K, Tobinai K, Fukuda H, Mukai K, Chou T, Mikuni C, Kinoshita T, Fukushima N, Kiyama Y, Suzuki T, Sasaki T, Watanabe Y, Tsukasaki K, Hotta T, Shimoyama M, Ogura M; Lymphoma Study Group of the Japan Clinical Oncology Group. Kagami Y, et al. Int J Hematol. 2012 Jul;96(1):74-83. doi: 10.1007/s12185-012-1101-2. Epub 2012 Jun 3. Int J Hematol. 2012. PMID: 22661011 Clinical Trial.
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).
Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K, Takeshita A, Saito K, Hasegawa S, Shimodaira S, Tamura J, Shimazaki C, Matsue K, Kobayashi H, Arima N, Suzuki R, Morishita H, Saito H, Ueda R, Ohno R. Kiyoi H, et al. Among authors: ueda r. Leukemia. 1997 Sep;11(9):1447-52. doi: 10.1038/sj.leu.2400756. Leukemia. 1997. PMID: 9305596
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motoji T, Omoto E, Saito H, Ohno R, Ueda R. Kiyoi H, et al. Among authors: ueda r. Blood. 1999 May 1;93(9):3074-80. Blood. 1999. PMID: 10216104 Free article. Clinical Trial.
Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, Am80, after relapse from CR induced by all-trans-retinoic acid.
Shinjo K, Takeshita A, Ohnishi K, Sakura T, Miyawaki S, Hiraoka A, Takeuchi M, Tomoyasu S, Wakita H, Ata K, Fukutani H, Ueda R, Ohno R; Koseisho Leukemia Study Group. Shinjo K, et al. Among authors: ueda r. Int J Hematol. 2000 Dec;72(4):470-3. Int J Hematol. 2000. PMID: 11197214 Clinical Trial.
1,128 results